cme 550. | Rating BUY
Dabur India Ltd.
rarest td
“arcet 665 (12m)| Upside 24.7%
@B INDsEC
Positive Outlook...
Bleonber se ABR
Recier nr 2 The quarter witnessed an unprecedented rise in raw material prices and inflationary pressure, which impacted
‘margins and demand inthe rural and urban markets. However, though various measures, Daur mitigated some
aaaeee I roi Torin, te rc sowdown ad penta cept bese matt corny eed So oy.
7 monic | i conape eles coped domandteoph LP poacs To meet arate comps
- duced its advertisement spends (209bps YoY) and took a blended price hike of ~6%. Despite many headwinds,
tain stn tena Dabur was able to gain market share in 95% of its portfolio. This demonstrates Dabur’s strong brand equity in
eee eee 022 consumers mind. We believe, going forward a good harvest and a recent announcement by the Govt. to increase
mae (MSP of rabi crops will enable recovery in the rural economy. We believe, Dabur's long-term growth is intact. We
ae Edel ‘expect softness in global commodity prices and improvement in the supply chain would further aid softness in
ene asl domestic inflation and lead to a revival in consumer demand.
lenin il We believe, recent acquisition of Badshah Masala will help Dabur to expand its “ood product vertical and be part
CN vino nna
Ronee ets) on a cansted tev, bute repo revenue growth of 60% Yoo RES dy nl buns
oe ee he Roe Eee) which grew by 6.0% and international business grew by 12.3% in CC terms, EBITDA for the quarter declined by 3.2%
vere scen nate meg conned tn Yovto104% on mrt ot hp at Sereno meg
However, 209bps YOY decline in Advertisement & Sales expenses restricted further contraction, Ad. PAT for the
quarter de-grew by 2.5% YoY to Rs.4.9bn, while margin contracted 1€8bps VoY to 16% on account oa subsied
Revenue fa ee ee mee]
tae mo she oe Reve Mi
an a pad ea an Ce
see TT eee
res seit iaald avals aS “pir 60 62 54 3.2% 10.5%
a Senn mee | (EBTOAPS 201% 420% 19.3% -191bps _c5bps | Pomestic eee eee
Ce
: sows) te 173% 1808 10m sie
Gavenan' Secs atee
‘OcroMER ST, 2002
Inde Ree ao sali a tno nd Beombeng RESP SFL cd, Tomon Rafe au aeINDSEC
a.
Conference Call Highlights
Heatencare segment quarterly revenue trend (Rs.bn)___ Healthcare portfolio: Healthcare portfolio declined 7.0% YoY on high base of Q2FV22 &
ora
= + Health supplement declined 12.6% YoY on high bases of Chyawanprast and Honey
. However, during the quarter, Jabur improved its market share in Chyawanprash and
. om Honey by 1206ps/40bps respectively
so Sim + OTC & Ethical portfolio destined by 0.2% YOY due to high base of